Published in N Engl J Med on November 18, 2013
Improving Mitral Repair for Functional Mitral Regurgitation (IMPROVE-FMR) | NCT03366649
Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2014) 3.89
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Preoperative Three-Dimensional Valve Analysis Predicts Recurrent Ischemic Mitral Regurgitation After Mitral Annuloplasty. Ann Thorac Surg (2015) 2.59
Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey. BMJ (2016) 2.12
Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve. J Am Coll Cardiol (2016) 1.49
Cardiac surgery 2014 reviewed. Clin Res Cardiol (2015) 1.42
Mitral valve area during exercise after restrictive mitral valve annuloplasty: importance of diastolic anterior leaflet tethering. J Am Coll Cardiol (2015) 1.41
Mitral valve repair versus replacement for ischemic mitral regurgitation: controversy remains alive - letter 2. Ann Thorac Surg (2015) 1.11
Mitral valve repair versus replacement. Ann Cardiothorac Surg (2015) 0.98
Surgery for severe ischemic mitral regurgitation. N Engl J Med (2014) 0.95
Surgery for severe ischemic mitral regurgitation. N Engl J Med (2014) 0.94
The rise of multiple imputation: a review of the reporting and implementation of the method in medical research. BMC Med Res Methodol (2015) 0.94
Surgery for severe ischemic mitral regurgitation. N Engl J Med (2014) 0.93
Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty. Circulation (2016) 0.91
Mitral valve disease-morphology and mechanisms. Nat Rev Cardiol (2015) 0.84
Basic mechanisms of mitral regurgitation. Can J Cardiol (2014) 0.83
Effect of myocardial perfusion pattern on frequency and severity of mitral regurgitation in patients with known or suspected coronary artery disease. Am J Cardiol (2014) 0.82
The value of preoperative 3-dimensional over 2-dimensional valve analysis in predicting recurrent ischemic mitral regurgitation after mitral annuloplasty. J Thorac Cardiovasc Surg (2016) 0.81
Myocardial perfusion pattern for stratification of ischemic mitral regurgitation response to percutaneous coronary intervention. Coron Artery Dis (2015) 0.80
Safety and feasibility of a novel adjustable mitral annuloplasty ring: a multicentre European experience†. Eur J Cardiothorac Surg (2015) 0.80
A meta-analysis of mitral valve repair versus replacement for ischemic mitral regurgitation. Ann Cardiothorac Surg (2015) 0.79
Undersized Mitral Annuloplasty Increases Strain in the Proximal Lateral Left Ventricular Wall. Ann Thorac Surg (2016) 0.79
Human Cardiac Function Simulator for the Optimal Design of a Novel Annuloplasty Ring with a Sub-valvular Element for Correction of Ischemic Mitral Regurgitation. Cardiovasc Eng Technol (2015) 0.79
Echocardiographic assessment of ischemic mitral regurgitation. Cardiovasc Ultrasound (2014) 0.79
Is chordal-preserving mitral valve replacement superior to valve repair in appropriately selected patients? J Thorac Dis (2016) 0.79
Surgery for severe ischemic mitral regurgitation. N Engl J Med (2014) 0.78
Ex Vivo Methods for Informing Computational Models of the Mitral Valve. Ann Biomed Eng (2016) 0.77
Coronary artery bypass grafting (CABG) alone in moderate ischemic mitral regurgitation: is CABG really enough? Ann Transl Med (2016) 0.76
Managing mitral regurgitation: focus on the MitraClip device. Med Devices (Auckl) (2016) 0.75
Catheter-based or surgical repair of the highest risk secondary mitral regurgitation patients. Ann Cardiothorac Surg (2015) 0.75
Mitral valve repair for ischemic mitral regurgitation. Ann Cardiothorac Surg (2015) 0.75
Cardiothoracic Surgical Trials Network: Evidence-based surgery. J Thorac Cardiovasc Surg (2015) 0.75
Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty". Circulation (2017) 0.75
Finite Element Analysis of Patient-Specific Mitral Valve with Mitral Regurgitation. Cardiovasc Eng Technol (2017) 0.75
The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability. J Cardiothorac Surg (2016) 0.75
Percutaneous coronary intervention for acute myocardial infarction with mitral regurgitation. J Geriatr Cardiol (2016) 0.75
Mechanical dyssynchrony and deformation imaging in patients with functional mitral regurgitation. World J Cardiol (2016) 0.75
Has moderate ischemic mitral regurgitation to be corrected?-Analysis of a randomized trial. Ann Transl Med (2016) 0.75
Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications. Circulation (2017) 0.75
Ischemic mitral valve prolapse. J Thorac Dis (2016) 0.75
Repair or replace for severe ischemic mitral regurgitation: prospective randomized multicenter data. Ann Cardiothorac Surg (2015) 0.75
Is Mitral Valve Repair Superior to Mitral Valve Replacement in Elderly Patients? Comparison of Short- and Long-Term Outcomes in a Propensity-Matched Cohort. J Am Heart Assoc (2016) 0.75
Reply: To PMID 24245543. Ann Thorac Surg (2015) 0.75
Echocardiographic assessment of mitral valve regurgitation, pattern and prevalence, expanding clinical awareness through an institutional survey with the perspective of a quality improvement project. Clin Med Insights Cardiol (2014) 0.75
Valvular disease: mitral valve repair and replacement compared. Nat Rev Cardiol (2013) 0.75
Mitral valve repair for ischemic mitral regurgitation: lessons from the Cardiothoracic Surgical Trials Network randomized study. J Thorac Dis (2016) 0.75
A novel approach to ischemic mitral regurgitation (IMR). Ann Cardiothorac Surg (2015) 0.75
Mitral valve repair. F1000Res (2016) 0.75
The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan. Nagoya J Med Sci (2016) 0.75
Pathophysiology and management of multivalvular disease. Nat Rev Cardiol (2016) 0.75
Mitral Valve Annuloplasty Ring Dehiscence Diagnosed Intraoperative With Real-Time 3D Transesophageal Echocardiogram. J Investig Med High Impact Case Rep (2014) 0.75
CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation? Glob Cardiol Sci Pract (2015) 0.75
Surgical management of moderate ischemic mitral valve regurgitation: Where do we stand? World J Cardiol (2014) 0.75
Design, Analysis and Testing of a Novel Mitral Valve for Transcatheter Implantation. Ann Biomed Eng (2017) 0.75
Mitral Valve Disease: a Comprehensive Review. Curr Cardiol Rep (2017) 0.75
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med (2009) 12.44
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation (1987) 7.14
Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation (2001) 3.94
Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation (2005) 3.86
Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg (2001) 3.61
Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2004) 3.38
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation (1997) 2.64
Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study. Circulation (2000) 2.59
Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation (2005) 2.55
Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation (2003) 2.45
Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg (2001) 2.44
Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg (2009) 2.35
Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation (2004) 2.13
Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology (2008) 2.07
Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation (2004) 2.02
Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol (2010) 1.93
Effect of Valsartan on hospitalization: results from Val-HeFT. J Card Fail (2003) 1.77
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation (2005) 1.59
Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation (2006) 1.54
Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg (2010) 1.39
Mitral repair versus replacement for ischemic mitral regurgitation. Ann Thorac Surg (2005) 1.36
Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg (2008) 1.36
Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail (2009) 1.32
Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail (2003) 1.21
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg (2011) 1.17
Mitral valve surgery in advanced heart failure. J Am Coll Cardiol (2010) 1.17
End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy. Eur J Heart Fail (2010) 1.14
Mitral repair versus replacement for ischemic mitral regurgitation: comparison of short-term and long-term survival. Circulation (2009) 1.13
Mitral repair is superior to replacement when associated with coronary artery disease. Ann Surg (2004) 1.11
Impact of mitral regurgitation on long-term survival after percutaneous coronary intervention. Am J Cardiol (2002) 1.09
Comparison of valve annuloplasty and replacement for ischemic mitral valve incompetence. Heart Surg Forum (2008) 1.00
Does mitral valve intervention have an impact on late survival in ischemic cardiomyopathy? Isr Med Assoc J (2006) 0.98
Effect of systematic downsizing rigid ring annuloplasty in patients with moderate ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2013) 0.88
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
Universal definition of myocardial infarction. Circulation (2007) 11.69
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 7.41
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. N Engl J Med (2016) 4.67
Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant (2013) 4.60
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med (2006) 4.59
Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol (2010) 4.53
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol (2010) 4.52
A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 4.34
Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet (2003) 4.21
2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.20
Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA (2010) 4.13
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA (2011) 3.97
Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med (2003) 3.87
Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg (2002) 3.86
Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol (2006) 3.78
Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science (2012) 3.74
Procedural volume as a marker of quality for CABG surgery. JAMA (2004) 3.70
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59
Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol (2004) 3.50
Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med (2012) 3.47
Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg (2010) 3.45
Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA (2010) 3.39